| 查看: 284 | 回复: 0 | ||
jlucuixy银虫 (初入文坛)
|
[求助]
求助翻译，万分感谢@药物分析
|
|
With AOAC guidance under a contract with Elanco Animal Health, a Division of Eli Lilly and Company, candidate methods have been recommended for the second set of priority compounds: nicarbazin, apramycin, and avilamycin (candidate methods for the original compounds tylosin, tilmicosin, narasin, monensin, and ractopamine were recommended in June 2009; see November/December 2010 issue of ILM for an update on these compounds). On December 7-9, 2010, at AOAC headquarters in Gaithersburg, Maryland, USA, expert review panels (ERPs) evaluated 30 of the most promising and potential candidate methods for nicarbazin, apramycin, and avilamycin analysis in animal tissues. Fitness-for-purpose statements were meticulously developed against which candidate methods were reviewed. [ Last edited by jlucuixy on 2011-5-20 at 13:34 ] |
回复此楼» 猜你喜欢
297求调剂
已经有16人回复
-
326分，一志愿沪9，求生物学调剂
已经有4人回复
-
288求调剂，一志愿华南理工大学071005
已经有3人回复
-
304求调剂
已经有13人回复
-
调剂
已经有18人回复
-
293调剂
已经有4人回复
-
338求调剂
已经有7人回复
-
263求调剂
已经有3人回复
-
求调剂
已经有15人回复
-
机械工程264学硕求调剂
已经有3人回复
